Tag Archives: biotechnology

Deposit of Biological Material – Impact on Validity of Priority Claim

Posted on March 1, 2013 by Warren Woessner

Please find linked below a guest post from Dr. Stefan Danner dealing with a new decision of the EPO Technical Boards of Appeal concerning the deposit of biological material. Biotech IP Newsletter  

Posted in Int'l Practice and Policy | Tagged , , , , , | Leave a comment

Biotech’s PR Problems Continue

Posted on February 15, 2013 by Warren Woessner

Maybe “Fish gotta swim” but the FDA has extended the approval period for transgenic Salmon genetically engineered to reach market weight sooner. No evidence at all has been presented that filets from these fish would present a danger human consumers … Continue reading →

Posted in Govt Policy/PTO Policy, Transgenics | Tagged , , , | Leave a comment

Time For Myriad To Fight Another Day

Posted on February 4, 2013 by Warren Woessner

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule

Posted on January 17, 2013 by Warren Woessner

On December 19, 2012, the Patent Office published the final rule: “Changes to Implement Micro Entity Status for Paying Patents Fees” –77 Fed. Reg. 75019–and on January 18, 2013 the final fee schedule is expected to be published (link below). … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , | 1 Comment